Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Hexagon Nutrition Business Update

Hexagon Nutrition successfully completed commercial-scale process validation for its PFH-VAP (Vitamin A Palmitate) formulation. The company will now proceed with steps for commercializing the product under "VIT A+".

Source

NSE filing, NSE: HEXAGON. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Hexagon Nutrition Ltd: key numbers

Share price
₹56.59
Market cap
₹695.6 Cr
Revenue (annual)
₹382.6 Cr
Net profit (annual)
₹37.94 Cr
P/E (TTM)
17.6×Sector 38.3×
Promoter holding
64.36%+0.07% QoQ
FII holding
0.29%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Hexagon Nutrition Ltd

All →
19:00 IST NSE
Product Launch

Hexagon Nutrition Product Launch

Hexagon Nutrition has launched 'PFH-VAP', a stable formulation of Vitamin A Palmitate, across the African international market.

Other business update announcements

All →